$AHR
American Healthcare REIT, Inc. Stock $ahr

$ahr Overview Financials Valuation SEC Filings Company Website

2016 Q4 Form 10-K Financial Statement

#000163297018000035 Filed on March 08, 2018

Income Statement

Concept	2016 Q4	2016 Q3	2016 Q2
Revenue	$2.818M	$214.0K	$3.000K
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$40.00K	$0.00
YoY Change
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit	-$2.161M	-$2.036M	-$613.0K
YoY Change
Interest Expense		$56.00K	$0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net	$458.0K	$56.00K	$0.00
YoY Change
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings	-$2.619M	-$2.092M	-$613.0K
YoY Change
Net Earnings / Revenue	-92.94%	-977.57%	-20433.33%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding	7.784M shares	2.844M shares	359.1K shares
Diluted Shares Outstanding

Balance Sheet

Concept	2016 Q4	2016 Q3	2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$2.237M	$2.575M	$9.052M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles	$19.67M	$6.866M
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$142.8M	$65.66M	$15.34M
YoY Change	70572.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities	$50.50M	$22.70M	$3.425M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings	-$7.351M	-$3.453M	-$851.0K
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$92.26M	$42.95M	$11.91M
YoY Change
Total Liabilities & Shareholders Equity	$142.8M	$65.66M	$15.34M
YoY Change	70572.28%

Cashflow Statement

Concept	2016 Q4	2016 Q3	2016 Q2
OPERATING ACTIVITIES
Net Income	-$2.619M	-$2.092M	-$613.0K
YoY Change
Depreciation, Depletion And Amortization		$40.00K	$0.00
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017	dei	Amendment Flag AmendmentFlag	false
CY2017	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2017	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2017	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
CY2017	dei	Document Period End Date DocumentPeriodEndDate	2017-12-31
CY2017	dei	Document Type DocumentType	10-K
CY2017	dei	Entity Central Index Key EntityCentralIndexKey	0001632970
CY2017	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2017	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2015-01-23
CY2017Q2	dei	Entity Public Float EntityPublicFloat	283106000	USD
CY2017	dei	Entity Registrant Name EntityRegistrantName	Griffin-American Healthcare REIT IV, Inc.
CY2017	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2017	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2017	dei	Trading Symbol TradingSymbol	gahr4
CY2015Q4	gahr	Accrued Contingent Advisor Payment AccruedContingentAdvisorPayment	0	USD
CY2016Q4	gahr	Accrued Contingent Advisor Payment AccruedContingentAdvisorPayment	5404000	USD
CY2017Q4	gahr	Accrued Contingent Advisor Payment AccruedContingentAdvisorPayment	7744000	USD
CY2015Q4	gahr	Accruedstockholderservicingfee Accruedstockholderservicingfee	0	USD
CY2016Q4	gahr	Accruedstockholderservicingfee Accruedstockholderservicingfee	3973000	USD
CY2017Q4	gahr	Accruedstockholderservicingfee Accruedstockholderservicingfee	12611000	USD
CY2016Q4	gahr	Accumulated Amortization Lease Inducements AccumulatedAmortizationLeaseInducements	0	USD
CY2017Q4	gahr	Accumulated Amortization Lease Inducements AccumulatedAmortizationLeaseInducements	9000	USD
	gahr	Acquisition Aggregated Cost Of Acquired Properties Purchase Price AcquisitionAggregatedCostOfAcquiredPropertiesPurchasePrice	466140000	USD
CY2016	gahr	Adjustmentsto Additional Paidin Capital Fair Value Adjustmentto Redeemable Noncontrolling Interests AdjustmentstoAdditionalPaidinCapitalFairValueAdjustmenttoRedeemableNoncontrollingInterests	0	USD
CY2017	gahr	Adjustmentsto Additional Paidin Capital Fair Value Adjustmentto Redeemable Noncontrolling Interests AdjustmentstoAdditionalPaidinCapitalFairValueAdjustmenttoRedeemableNoncontrollingInterests	33000	USD
CY2017	gahr	Advisory Agreement Term AdvisoryAgreementTerm	P1Y
CY2016Q1	gahr	Advisory Agreement Term AdvisoryAgreementTerm	P1Y
CY2016Q1	gahr	Aggregate Maximum Amount Of Common Stock Issuable Under Public Offering AggregateMaximumAmountOfCommonStockIssuableUnderPublicOffering	3150000000	USD
CY2016Q2	gahr	Aggregate Reallocated Maximum Amountof Common Stock Issuable Under Primary Public Offering AggregateReallocatedMaximumAmountofCommonStockIssuableUnderPrimaryPublicOffering	3150000000	USD
CY2017	gahr	Amortization Expense On Lease Commissions AmortizationExpenseOnLeaseCommissions	9000	USD
	gahr	Amortizationof Identified Intangible Liabilities AmortizationofIdentifiedIntangibleLiabilities	0	USD
CY2016	gahr	Amortizationof Identified Intangible Liabilities AmortizationofIdentifiedIntangibleLiabilities	60000	USD
CY2017	gahr	Amortizationof Identified Intangible Liabilities AmortizationofIdentifiedIntangibleLiabilities	291000	USD
CY2016	gahr	Amortizationofdeferredfinancingcostsrelatedtomortgage Amortizationofdeferredfinancingcostsrelatedtomortgage	2000	USD
CY2017	gahr	Amortizationofdeferredfinancingcostsrelatedtomortgage Amortizationofdeferredfinancingcostsrelatedtomortgage	38000	USD
CY2016	gahr	Assetmanagementfeeswaivedbyadvisor Assetmanagementfeeswaivedbyadvisor	80000	USD
CY2016	gahr	Borrowingsandassumptionsonmortgageloanspayablenet Borrowingsandassumptionsonmortgageloanspayablenet	4129000	USD
CY2017	gahr	Borrowingsandassumptionsonmortgageloanspayablenet Borrowingsandassumptionsonmortgageloanspayablenet	8000000	USD
CY2017	gahr	Capitalized Acquisition Costsand Fees Additions CapitalizedAcquisitionCostsandFeesAdditions	10984000	USD
CY2016	gahr	Capitalizeddeferredfinancingcostsformortgages Capitalizeddeferredfinancingcostsformortgages	103000	USD
CY2017	gahr	Capitalizeddeferredfinancingcostsformortgages Capitalizeddeferredfinancingcostsformortgages	150000	USD
	gahr	Common Stock Repuchased During Period Under Share Repurchase Plan Shares CommonStockRepuchasedDuringPeriodUnderShareRepurchasePlanShares	77746	shares
CY2017	gahr	Common Stock Repuchased During Period Under Share Repurchase Plan Shares CommonStockRepuchasedDuringPeriodUnderShareRepurchasePlanShares	77746	shares
CY2016	gahr	Dealer Manager Fees DealerManagerFees	1106000	USD
CY2017	gahr	Dealer Manager Fees DealerManagerFees	2844000	USD
CY2017Q4	gahr	Deferred Tax Assets Property Plant Equipment And Intangibles DeferredTaxAssetsPropertyPlantEquipmentAndIntangibles	388000	USD
CY2017	gahr	Direct Write Offs Of Deferred Rent Receivable DirectWriteOffsOfDeferredRentReceivable	2000	USD
CY2016	gahr	Distribution Classified As Capital Gain DistributionClassifiedAsCapitalGain	0	USD
CY2017	gahr	Distribution Classified As Capital Gain DistributionClassifiedAsCapitalGain	0	USD
CY2016	gahr	Distributions Classified As Ordinary Income DistributionsClassifiedAsOrdinaryIncome	0	USD
CY2017	gahr	Distributions Classified As Ordinary Income DistributionsClassifiedAsOrdinaryIncome	6021000	USD
CY2016	gahr	Distributions Classified As Return Of Capital DistributionsClassifiedAsReturnOfCapital	1345000	USD
CY2017	gahr	Distributions Classified As Return Of Capital DistributionsClassifiedAsReturnOfCapital	9055000	USD
CY2016	gahr	Distributions Reportable DistributionsReportable	1345000	USD
CY2017	gahr	Distributions Reportable DistributionsReportable	15076000	USD
CY2017Q4	gahr	Finite Lived Intangible Liabilities Amortization Expenses After Year Five FiniteLivedIntangibleLiabilitiesAmortizationExpensesAfterYearFive	692000	USD
CY2017Q4	gahr	Finite Lived Intangible Liabilities Amortization Expenses Remainder Of Fiscal Year FiniteLivedIntangibleLiabilitiesAmortizationExpensesRemainderOfFiscalYear	338000	USD
CY2017Q4	gahr	Finite Lived Intangible Liabilities Amortization Expenses Year Five FiniteLivedIntangibleLiabilitiesAmortizationExpensesYearFive	125000	USD
CY2017Q4	gahr	Finite Lived Intangible Liabilities Amortization Expenses Year Four FiniteLivedIntangibleLiabilitiesAmortizationExpensesYearFour	125000	USD
CY2017Q4	gahr	Finite Lived Intangible Liabilities Amortization Expenses Year Three FiniteLivedIntangibleLiabilitiesAmortizationExpensesYearThree	147000	USD
CY2017Q4	gahr	Finite Lived Intangible Liabilities Amortization Expenses Year Two FiniteLivedIntangibleLiabilitiesAmortizationExpensesYearTwo	310000	USD
CY2017Q4	gahr	Finite Lived Intangible Liabilities Net FiniteLivedIntangibleLiabilitiesNet	1737000	USD
CY2016	gahr	Finite Lived Intangible Liabilities Useful Life FiniteLivedIntangibleLiabilitiesUsefulLife	P5Y4M24D
CY2017	gahr	Finite Lived Intangible Liabilities Useful Life FiniteLivedIntangibleLiabilitiesUsefulLife	P16Y8M12D
CY2016Q3	gahr	Line Of Credit Facility Number Of Potential Extensions LineOfCreditFacilityNumberOfPotentialExtensions	1	Extension_period
CY2017Q4	gahr	Line Of Credit Facility Number Of Potential Extensions LineOfCreditFacilityNumberOfPotentialExtensions	1	Extension_period
CY2016Q3	gahr	Line Of Credit Facility Potential Extension Term LineOfCreditFacilityPotentialExtensionTerm	P12M
CY2017Q4	gahr	Line Of Credit Facility Potential Extension Term LineOfCreditFacilityPotentialExtensionTerm	P12M
CY2016Q4	gahr	Linesofcreditandtermloannet Linesofcreditandtermloannet	32957000	USD
CY2017Q4	gahr	Linesofcreditandtermloannet Linesofcreditandtermloannet	82644000	USD
	gahr	Maximumpercentageofdealermanagerfee Maximumpercentageofdealermanagerfee	0.03
CY2017Q4	gahr	Maximum Investment Rate By Officer Evp MaximumInvestmentRateByOfficerEVP	0.15
CY2016Q1	gahr	Maximum Investment Rate By Officer Evp MaximumInvestmentRateByOfficerEVP	0.15
	gahr	Maximumpercentageofdealermanagerfee Maximumpercentageofdealermanagerfee	0.030
CY2016Q1	gahr	Maximum Percentage Of Common Stock Repurchased During Period MaximumPercentageOfCommonStockRepurchasedDuringPeriod	0.050
	gahr	Maximum Percentage Of Fees And Expenses Associated With Acquisition MaximumPercentageOfFeesAndExpensesAssociatedWithAcquisition	0.06
CY2016	gahr	Maximum Percentage Of Fees And Expenses Associated With Acquisition MaximumPercentageOfFeesAndExpensesAssociatedWithAcquisition	0.060
CY2017	gahr	Maximumpercentageofdealermanagerfee Maximumpercentageofdealermanagerfee	0.030
CY2017Q3	gahr	Maximum Percentage Of Fees And Expenses Associated With Acquisition MaximumPercentageOfFeesAndExpensesAssociatedWithAcquisition	0.06
CY2017	gahr	Maximum Percentage Of Fees And Expenses Associated With Acquisition MaximumPercentageOfFeesAndExpensesAssociatedWithAcquisition	0.06
CY2017	gahr	Maximumpercentageofdealermanagerfee Maximumpercentageofdealermanagerfee	0.03
CY2017	gahr	Maximumpercentageofstockholderservicingfee Maximumpercentageofstockholderservicingfee	0.040
CY2017Q4	gahr	Minimum Investment Rate By Officer Evp MinimumInvestmentRateByOfficerEVP	0.05
CY2016Q1	gahr	Minimum Investment Rate By Officer Evp MinimumInvestmentRateByOfficerEVP	0.1
CY2017Q4	gahr	Minimum Percent Share Of Annualized Base Rent Accounted By Tenants MinimumPercentShareOfAnnualizedBaseRentAccountedByTenants	0.1
CY2017Q4	gahr	Minimum Percent Share Of Each State Annualized Base Rent That Company Owned MinimumPercentShareOfEachStateAnnualizedBaseRentThatCompanyOwned	0.1
CY2016	gahr	Mortgage Loans Payable Related To Acquisition Of Properties MortgageLoansPayableRelatedToAcquisitionOfProperties	3968000	USD
CY2017	gahr	Mortgage Loans Payable Related To Acquisition Of Properties MortgageLoansPayableRelatedToAcquisitionOfProperties	8000000	USD
	gahr	Noncashreclassificationofnoncontrollinginterest Noncashreclassificationofnoncontrollinginterest	0	USD
CY2016	gahr	Noncashreclassificationofnoncontrollinginterest Noncashreclassificationofnoncontrollinginterest	2000	USD
CY2017	gahr	Noncashreclassificationofnoncontrollinginterest Noncashreclassificationofnoncontrollinginterest	0	USD
	gahr	Number Of Buildings Acquired From Unaffiliated Parties NumberOfBuildingsAcquiredFromUnaffiliatedParties	40	Building
CY2016Q4	gahr	Number Of Fixed Rate Mortgage Loans Payable NumberOfFixedRateMortgageLoansPayable	1	MortgageLoan
CY2017Q4	gahr	Number Of Fixed Rate Mortgage Loans Payable NumberOfFixedRateMortgageLoansPayable	2	MortgageLoan
CY2017Q4	gahr	Number Of Tenants With More Than Ten Percent Of Annual Base Rent NumberOfTenantsWithMoreThanTenPercentOfAnnualBaseRent	2	tenant
	gahr	Numberof Acquisitions Completedfrom Unaffiliated Parties NumberofAcquisitionsCompletedfromUnaffiliatedParties	18	Acquisition
CY2017	gahr	Numberof Acquisitions Completedfrom Unaffiliated Parties NumberofAcquisitionsCompletedfromUnaffiliatedParties	9	Acquisition
	gahr	Numberof Properties Acquiredfrom Unaffiliated Parties NumberofPropertiesAcquiredfromUnaffiliatedParties	38	Property
CY2016Q1	gahr	Officer Purchase Share Price OfficerPurchaseSharePrice	9.60
	gahr	Other Amortization OtherAmortization	0	USD
CY2016	gahr	Other Amortization OtherAmortization	104000	USD
CY2017	gahr	Other Amortization OtherAmortization	415000	USD
CY2017	gahr	Ownership Percentage Properties OwnershipPercentageProperties	1
CY2015	gahr	Payments For Proceeds From Security Deposits Financing Activities PaymentsForProceedsFromSecurityDepositsFinancingActivities	0	USD
CY2016	gahr	Payments For Proceeds From Security Deposits Financing Activities PaymentsForProceedsFromSecurityDepositsFinancingActivities	0	USD
CY2017	gahr	Payments For Proceeds From Security Deposits Financing Activities PaymentsForProceedsFromSecurityDepositsFinancingActivities	-96000	USD
	gahr	Paymentsfor Preacquisitionexpenses PaymentsforPreacquisitionexpenses	0	USD
CY2016	gahr	Paymentsfor Preacquisitionexpenses PaymentsforPreacquisitionexpenses	0	USD
CY2017	gahr	Paymentsfor Preacquisitionexpenses PaymentsforPreacquisitionexpenses	334000	USD
CY2016	gahr	Percentage Distributions Reportable PercentageDistributionsReportable	1
CY2017	gahr	Percentage Distributions Reportable PercentageDistributionsReportable	1
	gahr	Percentage Of Dealer Manager Fee PercentageOfDealerManagerFee	0.010
	gahr	Percentage Of Dealer Manager Fee PercentageOfDealerManagerFee	0.01
	gahr	Percentage Of Dealer Manager Fee PercentageOfDealerManagerFee	0.010
	gahr	Percentage Of Dealer Manager Fee PercentageOfDealerManagerFee	0.01
CY2016	gahr	Percentage Of Distributions Classified As Capital Gain PercentageOfDistributionsClassifiedAsCapitalGain	0.00
CY2017	gahr	Percentage Of Distributions Classified As Capital Gain PercentageOfDistributionsClassifiedAsCapitalGain	0
CY2016	gahr	Percentage Of Distributions Classified As Ordinary Income PercentageOfDistributionsClassifiedAsOrdinaryIncome	0.00
CY2017	gahr	Percentage Of Distributions Classified As Ordinary Income PercentageOfDistributionsClassifiedAsOrdinaryIncome	0.40
CY2016	gahr	Percentage Of Distributions Classified As Return Of Capital PercentageOfDistributionsClassifiedAsReturnOfCapital	1.00
CY2017	gahr	Percentage Of Distributions Classified As Return Of Capital PercentageOfDistributionsClassifiedAsReturnOfCapital	0.60
CY2016Q4	gahr	Percentage Of Income Required To Be Distributed As Dividends PercentageOfIncomeRequiredToBeDistributedAsDividends	0.900
	gahr	Preacquisitionexpenses Incurredbut Notyet Paid PreacquisitionexpensesIncurredbutNotyetPaid	0	USD
CY2016	gahr	Preacquisitionexpenses Incurredbut Notyet Paid PreacquisitionexpensesIncurredbutNotyetPaid	0	USD
CY2017	gahr	Preacquisitionexpenses Incurredbut Notyet Paid PreacquisitionexpensesIncurredbutNotyetPaid	75000	USD
CY2016	gahr	Proceedsfromredeemablenoncontrollinginterest Proceedsfromredeemablenoncontrollinginterest	0	USD
CY2017	gahr	Proceedsfromredeemablenoncontrollinginterest Proceedsfromredeemablenoncontrollinginterest	1000000	USD
CY2015Q4	gahr	Receivable From Transfer Agent ReceivableFromTransferAgent	0	USD
CY2016Q4	gahr	Receivable From Transfer Agent ReceivableFromTransferAgent	1015000	USD
CY2017Q4	gahr	Receivable From Transfer Agent ReceivableFromTransferAgent	471000	USD
CY2016	gahr	Reclassificationof Noncontrolling Interest ReclassificationofNoncontrollingInterest	2000	USD
CY2017	gahr	Reclassificationof Noncontrolling Interest ReclassificationofNoncontrollingInterest	0	USD
CY2016	gahr	Selling Commissions Expenses SellingCommissionsExpenses	3045000	USD
CY2017	gahr	Selling Commissions Expenses SellingCommissionsExpenses	8329000	USD
	gahr	Selling Commissions Percentage SellingCommissionsPercentage	0.030
CY2016Q1	gahr	Share Repurchase Plan Holding Period Condition One ShareRepurchasePlanHoldingPeriodConditionOne	P1Y
CY2016Q1	gahr	Share Repurchase Plan Percentageof Priceper Share Condition One ShareRepurchasePlanPercentageofPriceperShareConditionOne	0.925
CY2016Q1	gahr	Share Repurchase Plan Percentageof Priceper Share Condition Two ShareRepurchasePlanPercentageofPriceperShareConditionTwo	1.00
	gahr	Sharesissuedindiscount Sharesissuedindiscount	0	USD
CY2016	gahr	Sharesissuedindiscount Sharesissuedindiscount	59000	USD
CY2017	gahr	Sharesissuedindiscount Sharesissuedindiscount	3000	USD
	gahr	Stock Acquired Average Cost Per Share StockAcquiredAverageCostPerShare	9.45
CY2017	gahr	Stock Acquired Average Cost Per Share StockAcquiredAverageCostPerShare	9.45
	gahr	Stock Repuchased During Period Value Under Share Repurchase Plan Value StockRepuchasedDuringPeriodValueUnderShareRepurchasePlanValue	735000	USD
CY2017	gahr	Stock Repuchased During Period Value Under Share Repurchase Plan Value StockRepuchasedDuringPeriodValueUnderShareRepurchasePlanValue	735000	USD
CY2016	gahr	Stockholder Servicing Fee Incurred StockholderServicingFeeIncurred	4052000	USD
CY2017	gahr	Stockholder Servicing Fee Incurred StockholderServicingFeeIncurred	10421000	USD
CY2016Q4	gahr	Stockholder Servicing Fee Payable StockholderServicingFeePayable	3973000	USD
CY2017Q4	gahr	Stockholder Servicing Fee Payable StockholderServicingFeePayable	12611000	USD
	gahr	Stockholderdailyservicingfeepercentage Stockholderdailyservicingfeepercentage	0.010
CY2016Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	5426000	USD
CY2017Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	19428000	USD
CY2016Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	1299000	USD
CY2017Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	2838000	USD
CY2016Q4	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	112000	USD
CY2017Q4	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	554000	USD
CY2016Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	99492000	USD
CY2017Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	376284000	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	50000	USD
CY2017	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	86000	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	13618000	USD
CY2017	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	29028000	USD
CY2016Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	USD
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	83000	USD
CY2016	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3000	USD
CY2017	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	13000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	0	USD
CY2016	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	112000	USD
CY2017	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	442000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	USD
CY2016	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	483000	USD
CY2017	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5732000	USD
CY2017Q4	us-gaap	Area Of Real Estate Property AreaOfRealEstateProperty	2317000	sqft
CY2016	us-gaap	Asset Management Fees1 AssetManagementFees1	151000	USD
	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	0	USD
CY2016	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	14000	USD
CY2016Q4	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0525
CY2017	us-gaap	Asset Management Fees1 AssetManagementFees1	2344000	USD
CY2016Q4	us-gaap	Assets Assets	142758000	USD
CY2016Q4	us-gaap	Assets Assets	142758000	USD
CY2017Q4	us-gaap	Assets Assets	480153000	USD
CY2017Q4	us-gaap	Assets Assets	480153000	USD
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	0	USD
CY2016	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	4745000	USD
CY2017	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	655000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	USD
CY2016	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	USD
CY2017	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1355000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	202000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2237000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7087000	USD
CY2015Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	202000	USD
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2237000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7103000	USD
CY2015Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	0	USD
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	202000	USD
CY2016	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	2035000	USD
CY2017	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	4866000	USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.40
CY2017	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.60
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000	shares
	us-gaap	Cost Of Real Estate Revenue CostOfRealEstateRevenue	0	USD
CY2016	us-gaap	Cost Of Real Estate Revenue CostOfRealEstateRevenue	898000	USD
CY2017	us-gaap	Cost Of Real Estate Revenue CostOfRealEstateRevenue	7292000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	0	USD
CY2016Q1	us-gaap	Costs And Expenses CostsAndExpenses	150000	USD
CY2016Q2	us-gaap	Costs And Expenses CostsAndExpenses	639000	USD
CY2016Q3	us-gaap	Costs And Expenses CostsAndExpenses	2348000	USD
CY2016Q4	us-gaap	Costs And Expenses CostsAndExpenses	4979000	USD
CY2016	us-gaap	Costs And Expenses CostsAndExpenses	8116000	USD
CY2017Q1	us-gaap	Costs And Expenses CostsAndExpenses	3719000	USD
CY2017Q2	us-gaap	Costs And Expenses CostsAndExpenses	5169000	USD
CY2017Q3	us-gaap	Costs And Expenses CostsAndExpenses	6954000	USD
CY2017Q4	us-gaap	Costs And Expenses CostsAndExpenses	14285000	USD
CY2017	us-gaap	Costs And Expenses CostsAndExpenses	30127000	USD
CY2016Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	3908000	USD
CY2017Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	11634000	USD
CY2017Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	11634000	USD
CY2017	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	2000	USD
CY2016Q4	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.0430
CY2017Q4	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.0345
CY2016Q4	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet	0	USD
CY2017Q4	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet	326000	USD
CY2016Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	943000	USD
CY2017Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	1456000	USD
CY2016Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	207000	USD
CY2017Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	1912000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2017Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	129000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	-41000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	476000	USD
	us-gaap	Depreciation Depreciation	0	USD
CY2016	us-gaap	Depreciation Depreciation	822000	USD
CY2017	us-gaap	Depreciation Depreciation	8137000	USD
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	0	USD
CY2016	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1252000	USD
CY2017	us-gaap	Depreciation And Amortization DepreciationAndAmortization	13639000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	0	USD
CY2016	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1252000	USD
CY2017	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	13639000	USD
CY2016	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	1877000	USD
CY2017	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	16672000	USD
CY2015Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	0	USD
CY2016Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	532000	USD
CY2017Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	2117000	USD
CY2016Q4	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	5531000	USD
CY2017Q4	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	8118000	USD
CY2016Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	5531000	USD
CY2017Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	8118000	USD
CY2016Q4	us-gaap	Earnest Money Deposits EarnestMoneyDeposits	200000	USD
CY2017Q4	us-gaap	Earnest Money Deposits EarnestMoneyDeposits	500000	USD
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.00
CY2016Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-7.20
CY2016Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.96
CY2016Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.62
CY2016Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.31
CY2016	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-1.75
CY2017Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.01
CY2017Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.03
CY2017Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.02
CY2017Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.02
CY2017	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.02
CY2016	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P28Y7M6D
CY2017	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P16Y2M12D
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	2945000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	16775000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	13334000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	3462000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	3857000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	4448000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	44821000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	0	USD
CY2016	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1221000	USD
CY2017	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4338000	USD
	us-gaap	Health Care Organization Resident Service Revenue HealthCareOrganizationResidentServiceRevenue	0	USD
CY2016	us-gaap	Health Care Organization Resident Service Revenue HealthCareOrganizationResidentServiceRevenue	0	USD
CY2017	us-gaap	Health Care Organization Resident Service Revenue HealthCareOrganizationResidentServiceRevenue	5563000	USD
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2016	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	USD
CY2017	us-gaap	Income Taxes Paid IncomeTaxesPaid	7000	USD
	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	0	USD
CY2016	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	284000	USD
CY2017	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	2166000	USD
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	0	USD
CY2016	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	770000	USD
CY2017	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2436000	USD
	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	0	USD
CY2016	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	127000	USD
CY2017	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	239000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	0	USD
CY2016	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-31000	USD
CY2017	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-274000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	0	USD
CY2016	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	17000	USD
CY2017	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	905000	USD
CY2016Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	19673000	USD
CY2017Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	44821000	USD
	us-gaap	Interest And Other Income InterestAndOtherIncome	0	USD
CY2016	us-gaap	Interest And Other Income InterestAndOtherIncome	0	USD
CY2017	us-gaap	Interest And Other Income InterestAndOtherIncome	1000	USD
	us-gaap	Interest Expense InterestExpense	0	USD
CY2016	us-gaap	Interest Expense InterestExpense	514000	USD
CY2017	us-gaap	Interest Expense InterestExpense	2699000	USD
	us-gaap	Interest Paid InterestPaid	0	USD
CY2016	us-gaap	Interest Paid InterestPaid	203000	USD
CY2017	us-gaap	Interest Paid InterestPaid	2052000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	50501000	USD
CY2017Q4	us-gaap	Liabilities Liabilities	125927000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	142758000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	480153000	USD
CY2016	us-gaap	Limited Liability Company Llc Or Limited Partnership Lp Managing Member Or General Partner Ownership Interest LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest	0.9999
CY2017	us-gaap	Limited Liability Company Llc Or Limited Partnership Lp Managing Member Or General Partner Ownership Interest LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest	0.9999
CY2016	us-gaap	Limited Liability Company Llc Or Limited Partnership Lp Members Or Limited Partners Ownership Interest LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest	0.0001
CY2017	us-gaap	Limited Liability Company Llc Or Limited Partnership Lp Members Or Limited Partners Ownership Interest LimitedLiabilityCompanyLLCOrLimitedPartnershipLPMembersOrLimitedPartnersOwnershipInterest	0.0001
CY2016Q4	us-gaap	Line Of Credit LineOfCredit	33900000	USD
CY2016Q4	us-gaap	Line Of Credit LineOfCredit	33900000	USD
CY2017Q4	us-gaap	Line Of Credit LineOfCredit	84100000	USD
CY2016Q3	us-gaap	Line Of Credit Facility Collateral LineOfCreditFacilityCollateral	750000000
CY2016Q4	us-gaap	Line Of Credit Facility Fair Value Of Amount Outstanding LineOfCreditFacilityFairValueOfAmountOutstanding	33899000	USD
CY2017Q4	us-gaap	Line Of Credit Facility Fair Value Of Amount Outstanding LineOfCreditFacilityFairValueOfAmountOutstanding	84088000	USD
CY2016Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	100000000	USD
CY2017Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	200000000	USD
CY2017Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	200000000	USD
CY2016Q4	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	66100000	USD
CY2017Q4	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	115900000	USD
CY2016Q4	us-gaap	Loans Payable Fair Value Disclosure LoansPayableFairValueDisclosure	4131000	USD
CY2017Q4	us-gaap	Loans Payable Fair Value Disclosure LoansPayableFairValueDisclosure	11819000	USD
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	2161000	USD
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	330000	USD
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	313000	USD
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	8036000	USD
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	407000	USD
CY2017Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	387000	USD
CY2016Q4	us-gaap	Minority Interest Ownership Percentage By Noncontrolling Owners MinorityInterestOwnershipPercentageByNoncontrollingOwners	0.0001
CY2017Q4	us-gaap	Minority Interest Ownership Percentage By Noncontrolling Owners MinorityInterestOwnershipPercentageByNoncontrollingOwners	0.0001
CY2016Q4	us-gaap	Minority Interest Ownership Percentage By Parent MinorityInterestOwnershipPercentageByParent	0.9999
CY2017Q4	us-gaap	Minority Interest Ownership Percentage By Parent MinorityInterestOwnershipPercentageByParent	0.9999
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	202000	USD
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	138978000	USD
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	323150000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	USD
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-133322000	USD
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-330688000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	0	USD
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3621000	USD
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	12404000	USD
	us-gaap	Net Income Loss NetIncomeLoss	0	USD
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	-150000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	-613000	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	-2092000	USD
CY2016Q4	us-gaap	Net Income Loss NetIncomeLoss	-2619000	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	-5474000	USD
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	-85000	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	621000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	754000	USD
CY2017Q4	us-gaap	Net Income Loss NetIncomeLoss	-749000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	541000	USD
CY2016Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2016Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2016Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2016Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2017Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2017Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2017Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	USD
CY2017Q4	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-33000	USD
	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	0	USD
CY2016	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	0	USD
CY2017	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	-33000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	0	USD
CY2016	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	4129000	USD
CY2017	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	8000000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Other Assets Acquired1 NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1	0	USD
CY2016	us-gaap	Noncash Or Part Noncash Acquisition Other Assets Acquired1 NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1	239000	USD
CY2017	us-gaap	Noncash Or Part Noncash Acquisition Other Assets Acquired1 NoncashOrPartNoncashAcquisitionOtherAssetsAcquired1	236000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Other Liabilities Assumed1 NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1	0	USD
CY2016	us-gaap	Noncash Or Part Noncash Acquisition Other Liabilities Assumed1 NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1	648000	USD
CY2017	us-gaap	Noncash Or Part Noncash Acquisition Other Liabilities Assumed1 NoncashOrPartNoncashAcquisitionOtherLiabilitiesAssumed1	728000	USD
	us-gaap	Noncash Or Part Noncash Acquisition Payables Assumed1 NoncashOrPartNoncashAcquisitionPayablesAssumed1	0	USD
CY2016	us-gaap	Noncash Or Part Noncash Acquisition Payables Assumed1 NoncashOrPartNoncashAcquisitionPayablesAssumed1	212000	USD
CY2017	us-gaap	Noncash Or Part Noncash Acquisition Payables Assumed1 NoncashOrPartNoncashAcquisitionPayablesAssumed1	1731000	USD
	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	2000	USD
CY2017Q4	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2017Q4	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3
CY2017Q4	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	3	State
CY2016Q4	us-gaap	Off Market Lease Unfavorable OffMarketLeaseUnfavorable	1063000	USD
CY2017Q4	us-gaap	Off Market Lease Unfavorable OffMarketLeaseUnfavorable	1737000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	12449000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	245000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	246000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	246000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	246000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	246000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	11220000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Receivable OperatingLeasesFutureMinimumPaymentsReceivable	320736000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Receivable Current OperatingLeasesFutureMinimumPaymentsReceivableCurrent	33200000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Receivable In Five Years OperatingLeasesFutureMinimumPaymentsReceivableInFiveYears	30652000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Receivable In Four Years OperatingLeasesFutureMinimumPaymentsReceivableInFourYears	32653000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Receivable In Three Years OperatingLeasesFutureMinimumPaymentsReceivableInThreeYears	33585000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Receivable In Two Years OperatingLeasesFutureMinimumPaymentsReceivableInTwoYears	34182000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Receivable Thereafter OperatingLeasesFutureMinimumPaymentsReceivableThereafter	156464000	USD
	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	0	USD
CY2016	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	3156000	USD
CY2016	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	3156000	USD
CY2017	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	27770000	USD
	us-gaap	Operations Commenced Date1 OperationsCommencedDate1	2015-02-06
CY2016Q4	us-gaap	Other Assets OtherAssets	1407000	USD
CY2016Q4	us-gaap	Other Assets OtherAssets	1407000	USD
CY2016Q2	us-gaap	Other Expenses OtherExpenses	0	USD
CY2017Q4	us-gaap	Other Assets OtherAssets	5226000	USD
CY2017Q4	us-gaap	Other Assets OtherAssets	5226000	USD
CY2016Q1	us-gaap	Other Expenses OtherExpenses	0	USD
CY2016Q3	us-gaap	Other Expenses OtherExpenses	56000	USD
CY2016Q4	us-gaap	Other Expenses OtherExpenses	458000	USD
CY2017Q1	us-gaap	Other Expenses OtherExpenses	418000	USD
CY2017Q2	us-gaap	Other Expenses OtherExpenses	408000	USD
CY2017Q3	us-gaap	Other Expenses OtherExpenses	780000	USD
CY2017Q4	us-gaap	Other Expenses OtherExpenses	1092000	USD
CY2016Q4	us-gaap	Other Liabilities OtherLiabilities	616000	USD
CY2017Q4	us-gaap	Other Liabilities OtherLiabilities	977000	USD
	us-gaap	Owned Property Management Costs OwnedPropertyManagementCosts	0	USD
CY2016	us-gaap	Owned Property Management Costs OwnedPropertyManagementCosts	0	USD
CY2017	us-gaap	Owned Property Management Costs OwnedPropertyManagementCosts	4203000	USD
CY2016	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	5000	USD
CY2017	us-gaap	Participating Securities Distributed And Undistributed Earnings Loss Basic ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic	12000	USD
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	0	USD
CY2016	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	23000	USD
CY2017	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	1121000	USD
	us-gaap	Payments For Proceeds From Deposits On Real Estate Acquisitions PaymentsForProceedsFromDepositsOnRealEstateAcquisitions	0	USD
CY2016	us-gaap	Payments For Proceeds From Deposits On Real Estate Acquisitions PaymentsForProceedsFromDepositsOnRealEstateAcquisitions	200000	USD
CY2017	us-gaap	Payments For Proceeds From Deposits On Real Estate Acquisitions PaymentsForProceedsFromDepositsOnRealEstateAcquisitions	300000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2016	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2017	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	735000	USD
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	0	USD
CY2016	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	549000	USD
CY2017	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	6398000	USD
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
CY2016	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	1146000	USD
CY2017	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	1115000	USD
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
CY2016	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	4191000	USD
CY2017	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	18072000	USD
	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	0	USD
CY2016	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	133099000	USD
CY2017	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	328933000	USD
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
	us-gaap	Proceeds From Issuance Of Common Stock Dividend Reinvestment Plan ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan	796000	USD
CY2017Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	257000	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	1532000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	200000	USD
CY2016	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	111024000	USD
CY2017	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	298639000	USD
	us-gaap	Proceeds From Issuance Of Common Stock Dividend Reinvestment Plan ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan	9485000	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	USD
CY2016	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	90700000	USD
CY2017	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	308600000	USD
	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	2000	USD
CY2016	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	0	USD
CY2017	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	1000000	USD
	us-gaap	Profit Loss ProfitLoss	0	USD
CY2016Q1	us-gaap	Profit Loss ProfitLoss	-150000	USD
CY2016Q2	us-gaap	Profit Loss ProfitLoss	-613000	USD
CY2016Q3	us-gaap	Profit Loss ProfitLoss	-2092000	USD
CY2016Q4	us-gaap	Profit Loss ProfitLoss	-2619000	USD
CY2016	us-gaap	Profit Loss ProfitLoss	-5474000	USD
CY2017Q1	us-gaap	Profit Loss ProfitLoss	-85000	USD
CY2017Q2	us-gaap	Profit Loss ProfitLoss	621000	USD
CY2017Q3	us-gaap	Profit Loss ProfitLoss	754000	USD
CY2017Q4	us-gaap	Profit Loss ProfitLoss	-782000	USD
CY2017	us-gaap	Profit Loss ProfitLoss	508000	USD
CY2015	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	USD
CY2016	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	USD
CY2017	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	83000	USD
CY2015Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	0	USD
CY2016Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	822000	USD
CY2017Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	8885000	USD
CY2017Q4	us-gaap	Real Estate Accumulated Depreciation RealEstateAccumulatedDepreciation	8885000	USD
CY2015	us-gaap	Real Estate Accumulated Depreciation Other Additions RealEstateAccumulatedDepreciationOtherAdditions	0	USD
CY2016	us-gaap	Real Estate Accumulated Depreciation Other Additions RealEstateAccumulatedDepreciationOtherAdditions	822000	USD
CY2017	us-gaap	Real Estate Accumulated Depreciation Other Additions RealEstateAccumulatedDepreciationOtherAdditions	8090000	USD
CY2015	us-gaap	Real Estate Accumulated Depreciation Other Deductions RealEstateAccumulatedDepreciationOtherDeductions	0	USD
CY2016	us-gaap	Real Estate Accumulated Depreciation Other Deductions RealEstateAccumulatedDepreciationOtherDeductions	0	USD
CY2017	us-gaap	Real Estate Accumulated Depreciation Other Deductions RealEstateAccumulatedDepreciationOtherDeductions	-27000	USD
CY2017Q4	us-gaap	Real Estate And Accumulated Depreciation Amount Of Encumbrances RealEstateAndAccumulatedDepreciationAmountOfEncumbrances	11634000	USD
CY2017Q4	us-gaap	Real Estate And Accumulated Depreciation Carrying Amount Of Buildings And Improvements RealEstateAndAccumulatedDepreciationCarryingAmountOfBuildingsAndImprovements	376348000	USD
CY2017Q4	us-gaap	Real Estate And Accumulated Depreciation Carrying Amount Of Land RealEstateAndAccumulatedDepreciationCarryingAmountOfLand	52202000	USD
CY2017Q4	us-gaap	Real Estate And Accumulated Depreciation Costs Capitalized Subsequent To Acquisition Improvements RealEstateAndAccumulatedDepreciationCostsCapitalizedSubsequentToAcquisitionImprovements	2648000	USD
CY2017Q4	us-gaap	Real Estate And Accumulated Depreciation Initial Cost Of Buildings And Improvements RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements	373700000	USD
CY2017Q4	us-gaap	Real Estate And Accumulated Depreciation Initial Cost Of Land RealEstateAndAccumulatedDepreciationInitialCostOfLand	52202000	USD
CY2017Q4	us-gaap	Real Estate Federal Income Tax Basis RealEstateFederalIncomeTaxBasis	465764000	USD
CY2015Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	0	USD
CY2016	us-gaap	Real Estate Improvements RealEstateImprovements	23000	USD
CY2017	us-gaap	Real Estate Improvements RealEstateImprovements	2476000	USD
CY2016Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	118764000	USD
CY2017Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	428550000	USD
CY2017Q4	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	428550000	USD
CY2015Q1	us-gaap	Real Estate Gross At Carrying Value RealEstateGrossAtCarryingValue	0	USD
	us-gaap	Real Estate Improvements RealEstateImprovements	0	USD
CY2016Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	822000	USD
CY2017Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	8885000	USD
CY2016Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	118764000	USD
CY2017Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	428550000	USD
CY2016Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	117942000	USD
CY2016Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	117942000	USD
CY2017Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	419665000	USD
CY2017Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	419665000	USD
	us-gaap	Real Estate Other Acquisitions RealEstateOtherAcquisitions	0	USD
CY2016	us-gaap	Real Estate Other Acquisitions RealEstateOtherAcquisitions	118741000	USD
CY2017	us-gaap	Real Estate Other Acquisitions RealEstateOtherAcquisitions	307384000	USD
	us-gaap	Real Estate Other Deductions RealEstateOtherDeductions	0	USD
CY2016	us-gaap	Real Estate Other Deductions RealEstateOtherDeductions	0	USD
CY2017	us-gaap	Real Estate Other Deductions RealEstateOtherDeductions	-74000	USD
CY2016Q1	us-gaap	Real Estate Revenue Net RealEstateRevenueNet	0	USD
CY2016Q2	us-gaap	Real Estate Revenue Net RealEstateRevenueNet	26000	USD
CY2016Q3	us-gaap	Real Estate Revenue Net RealEstateRevenueNet	312000	USD
CY2016Q4	us-gaap	Real Estate Revenue Net RealEstateRevenueNet	2818000	USD
CY2017Q1	us-gaap	Real Estate Revenue Net RealEstateRevenueNet	4052000	USD
CY2017Q2	us-gaap	Real Estate Revenue Net RealEstateRevenueNet	6198000	USD
CY2017Q3	us-gaap	Real Estate Revenue Net RealEstateRevenueNet	8488000	USD
CY2017Q4	us-gaap	Real Estate Revenue Net RealEstateRevenueNet	14595000	USD
CY2015Q4	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	0	USD
CY2016Q4	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	2000	USD
CY2016Q4	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	2000	USD
CY2017Q4	us-gaap	Redeemable Noncontrolling Interest Equity Fair Value RedeemableNoncontrollingInterestEquityFairValue	1002000	USD
CY2016	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	9112000	USD
CY2017	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	17650000	USD
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	USD
CY2016	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	56800000	USD
CY2017	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	258400000	USD
CY2016	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	60000	USD
CY2017	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	273000	USD
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	0	USD
CY2016	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	60000	USD
CY2017	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	273000	USD
CY2015Q4	us-gaap	Restricted Cash RestrictedCash	0	USD
CY2016Q4	us-gaap	Restricted Cash RestrictedCash	0	USD
CY2017Q4	us-gaap	Restricted Cash RestrictedCash	16000	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	0	USD
CY2017Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	16000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-7351000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-23482000	USD
CY2016	us-gaap	Revenues Revenues	2258000	USD
CY2017	us-gaap	Revenues Revenues	21838000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	0	USD
CY2016	us-gaap	Sales Revenue Net SalesRevenueNet	3156000	USD
CY2017	us-gaap	Sales Revenue Net SalesRevenueNet	33333000	USD
CY2015Q4	us-gaap	Secured Debt SecuredDebt	0	USD
CY2016Q4	us-gaap	Secured Debt SecuredDebt	3965000	USD
CY2017Q4	us-gaap	Secured Debt SecuredDebt	11567000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	0	USD
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	80000	USD
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	131000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	37500	shares
	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2016	us-gaap	Stock Issued1 StockIssued1	796000	USD
CY2017	us-gaap	Stock Issued1 StockIssued1	8689000	USD
	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	83717	shares
	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	1008075	shares
	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	0	USD
CY2016	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	796000	USD
CY2016	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	796000	USD
CY2017	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	8689000	USD
CY2017	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	8689000	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	200000	USD
CY2016	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	112148000	USD
CY2017	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	298076000	USD
CY2016	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	30000	USD
CY2017	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	45000	USD
CY2017	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	735000	USD
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	202000	USD
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	92255000	USD
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	92255000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	353224000	USD
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	353224000	USD
CY2015Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	0	USD
	us-gaap	Straight Line Rent Adjustments StraightLineRentAdjustments	0	USD
CY2016	us-gaap	Straight Line Rent Adjustments StraightLineRentAdjustments	-207000	USD
CY2017	us-gaap	Straight Line Rent Adjustments StraightLineRentAdjustments	-1705000	USD
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	20833	shares
CY2016Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	20833	shares
CY2016Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	635808	shares
CY2016Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	3357979	shares
CY2016	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	3131466	shares
CY2016Q4	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	8450304	shares
CY2017Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	14655107	shares
CY2017Q2	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	24035973	shares
CY2017Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	32593321	shares
CY2017Q4	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	39409207	shares
CY2017	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	27754701	shares
CY2017	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">1. Organization and Description of Business</font><font style="font-family:inherit;font-size:10pt;font-weight:bold;"> </font></div><div style="line-height:120%;padding-top:10px;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Griffin-American Healthcare REIT IV, Inc., a Maryland corporation, was incorporated on </font><font style="font-family:inherit;font-size:10pt;">January 23, 2015</font><font style="font-family:inherit;font-size:10pt;"> and therefore we consider that our date of inception. We were initially capitalized on </font><font style="font-family:inherit;font-size:10pt;">February 6, 2015</font><font style="font-family:inherit;font-size:10pt;">. We invest in a diversified portfolio of real estate properties, focusing primarily on medical office buildings, hospitals, skilled nursing facilities, senior housing and other healthcare-related facilities. We also operate healthcare-related facilities utilizing the structure permitted by</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the REIT Investment Diversification and Empowerment Act of 2007, which is commonly referred to as a “RIDEA” structure</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(the provisions of the Internal Revenue Code of 1986, as amended, or the Code, authorizing the RIDEA structure were enacted</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">as part of the Housing and Economic Recovery Act of 2008). We may also originate and acquire secured loans and real estate-related investments on an infrequent and opportunistic basis. We generally seek investments that produce current income. We qualified to be taxed as a real estate investment trust, or REIT, under the Code for federal income tax purposes beginning with our taxable year ended December 31, 2016, and we intend to continue to qualify to be taxed as a REIT.</font></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On February 16, 2016, we commenced our initial public offering, or our offering, in which we were initially offering to the public up to </font><font style="font-family:inherit;font-size:10pt;">$3,150,000,000</font><font style="font-family:inherit;font-size:10pt;"> in shares of our Class T common stock, consisting of up to </font><font style="font-family:inherit;font-size:10pt;">$3,000,000,000</font><font style="font-family:inherit;font-size:10pt;"> in shares of our Class T common stock at a price of </font><font style="font-family:inherit;font-size:10pt;">$10.00</font><font style="font-family:inherit;font-size:10pt;"> per share in our primary offering and up to </font><font style="font-family:inherit;font-size:10pt;">$150,000,000</font><font style="font-family:inherit;font-size:10pt;"> in shares of our Class T common stock for </font><font style="font-family:inherit;font-size:10pt;">$9.50</font><font style="font-family:inherit;font-size:10pt;"> per share pursuant to our distribution reinvestment plan, as amended, or the DRIP. Effective June 17, 2016, we reallocated certain of the unsold shares of Class T common stock being offered and began offering shares of Class I common stock, such that we are currently offering up to approximately </font><font style="font-family:inherit;font-size:10pt;">$2,800,000,000</font><font style="font-family:inherit;font-size:10pt;"> in shares of Class T common stock and </font><font style="font-family:inherit;font-size:10pt;">$200,000,000</font><font style="font-family:inherit;font-size:10pt;"> in shares of Class I common stock in our primary offering, and up to an aggregate of </font><font style="font-family:inherit;font-size:10pt;">$150,000,000</font><font style="font-family:inherit;font-size:10pt;"> in shares of our Class T and Class I common stock pursuant to the DRIP, aggregating up to </font><font style="font-family:inherit;font-size:10pt;">$3,150,000,000</font><font style="font-family:inherit;font-size:10pt;">. The shares of our Class T common stock in our primary offering are being offered at a price of </font><font style="font-family:inherit;font-size:10pt;">$10.00</font><font style="font-family:inherit;font-size:10pt;"> per share. The shares of our Class I common stock in our primary offering were being offered at a price of </font><font style="font-family:inherit;font-size:10pt;">$9.30</font><font style="font-family:inherit;font-size:10pt;"> per share prior to March 1, 2017, and are being offered at a price of </font><font style="font-family:inherit;font-size:10pt;">$9.21</font><font style="font-family:inherit;font-size:10pt;"> per share for all shares issued effective March 1, 2017. The shares of our Class T and Class I common stock issued pursuant to the DRIP were sold at a price of </font><font style="font-family:inherit;font-size:10pt;">$9.50</font><font style="font-family:inherit;font-size:10pt;"> per share prior to January 1, 2017, and are sold at a price of </font><font style="font-family:inherit;font-size:10pt;">$9.40</font><font style="font-family:inherit;font-size:10pt;"> per share for all shares issued pursuant to the DRIP effective January 1, 2017. After our board of directors determines an estimated net asset value, or NAV, per share of our common stock, share prices are expected to be adjusted to reflect the estimated NAV per share and, in the case of shares offered pursuant to our primary offering, up-front selling commissions and dealer manager fees other than those funded by Griffin-American Healthcare REIT IV Advisor, LLC, or Griffin-American Healthcare REIT IV Advisor, or our advisor. We will sell shares of our Class T and Class I common stock in our offering until February 16, 2019, unless extended by our board of directors as permitted under applicable law, or extended with respect to shares of our common stock offered pursuant to the DRIP. We reserve the right to reallocate the shares of common stock we are offering between the primary offering and the DRIP, and among classes of stock. As of </font><font style="font-family:inherit;font-size:10pt;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">, we had received and accepted subscriptions in our offering for </font><font style="font-family:inherit;font-size:10pt;">41,218,498</font><font style="font-family:inherit;font-size:10pt;"> aggregate shares of our Class T and Class I common stock, or approximately </font><font style="font-family:inherit;font-size:10pt;">$410,151,000</font><font style="font-family:inherit;font-size:10pt;">, excluding shares of our common stock issued pursuant to the DRIP. </font></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We conduct substantially all of our operations through Griffin-American Healthcare REIT IV Holdings, LP, or our operating partnership. We are externally advised by our advisor pursuant to an advisory agreement, or the Advisory Agreement, between us and our advisor. The Advisory Agreement was effective as of February 16, 2016 and had a </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;">-year term, subject to successive </font><font style="font-family:inherit;font-size:10pt;">one</font><font style="font-family:inherit;font-size:10pt;">-year renewals upon the mutual consent of the parties. The Advisory Agreement was last renewed pursuant to the mutual consent of the parties on February 14, 2018 and expires on February 16, 2019. Our advisor uses its best efforts, subject to the oversight and review of our board of directors, to, among other things, research, identify, review and make investments in and dispositions of properties and securities on our behalf consistent with our investment policies and objectives. Our advisor performs its duties and responsibilities under the Advisory Agreement as our fiduciary. Our advisor is </font><font style="font-family:inherit;font-size:10pt;">75.0%</font><font style="font-family:inherit;font-size:10pt;"> owned and managed by American Healthcare Investors, LLC, or American Healthcare Investors, and </font><font style="font-family:inherit;font-size:10pt;">25.0%</font><font style="font-family:inherit;font-size:10pt;"> owned by a wholly owned subsidiary of Griffin Capital Company, LLC, or Griffin Capital (formerly known as Griffin Capital Corporation), or collectively, our co-sponsors. American Healthcare Investors is </font><font style="font-family:inherit;font-size:10pt;">47.1%</font><font style="font-family:inherit;font-size:10pt;"> owned by AHI Group Holdings, LLC, or AHI Group Holdings, </font><font style="font-family:inherit;font-size:10pt;">45.1%</font><font style="font-family:inherit;font-size:10pt;"> indirectly owned by Colony NorthStar, Inc. (NYSE: CLNS), or Colony NorthStar (formerly known as NorthStar Asset Management Group Inc. prior to its merger with Colony Capital, Inc. and NorthStar Realty Finance Corp. on January 10, 2017), and </font><font style="font-family:inherit;font-size:10pt;">7.8%</font><font style="font-family:inherit;font-size:10pt;"> owned by James F. Flaherty III, a former partner of Colony NorthStar. We are not affiliated with Griffin Capital, Griffin Capital Securities, LLC, or our dealer manager, Colony NorthStar or Mr. Flaherty; however, we are affiliated with Griffin-American Healthcare REIT IV Advisor, American Healthcare Investors and AHI Group Holdings.</font></div><div style="line-height:120%;padding-top:10px;text-align:left;text-indent:33px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">We currently operate through </font><font style="font-family:inherit;font-size:10pt;">three</font><font style="font-family:inherit;font-size:10pt;"> reportable business segments — medical office buildings, senior housing and senior housing — RIDEA. As of </font><font style="font-family:inherit;font-size:10pt;">December 31, 2017</font><font style="font-family:inherit;font-size:10pt;">, we had completed </font><font style="font-family:inherit;font-size:10pt;">18</font><font style="font-family:inherit;font-size:10pt;"> property acquisitions whereby we owned </font><font style="font-family:inherit;font-size:10pt;">38</font><font style="font-family:inherit;font-size:10pt;"> properties, comprising </font><font style="font-family:inherit;font-size:10pt;">40</font><font style="font-family:inherit;font-size:10pt;"> buildings, or approximately </font><font style="font-family:inherit;font-size:10pt;">2,317,000</font><font style="font-family:inherit;font-size:10pt;"> square feet of gross leasable area, or GLA, for an aggregate contract purchase price of </font><font style="font-family:inherit;font-size:10pt;">$466,140,000</font><font style="font-family:inherit;font-size:10pt;">.</font></div></div>
CY2017	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:10px;text-indent:36px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of our accompanying consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, as well as the disclosure of contingent assets and liabilities, at the date of our consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates are made and evaluated on an on-going basis using information that is currently available as well as various other assumptions believed to be reasonable under the circumstances. Actual results could differ from those estimates, perhaps in material adverse ways, and those estimates could be different under different assumptions or conditions.</font></div></div>

Files In Submission

Name	View Source	Status
0001632970-18-000035-index-headers.html	Edgar Link	pending
0001632970-18-000035-index.html	Edgar Link	pending
0001632970-18-000035.txt	Edgar Link	pending
0001632970-18-000035-xbrl.zip	Edgar Link	pending
ex1045-gahr4thirdamendment.htm	Edgar Link	pending
ex1046-gahr4thirdamendment.htm	Edgar Link	pending
ex211-gahr4x10xk2017xq4.htm	Edgar Link	pending
ex311-gahr4x10xk2017xq4.htm	Edgar Link	pending
ex312-gahr4x10xk2017xq4.htm	Edgar Link	pending
ex321-gahr4x10xk2017xq4.htm	Edgar Link	pending
ex322-gahr4x10xk2017xq4.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
gahr-20171231.xml	Edgar Link	completed
gahr-20171231.xsd	Edgar Link	pending
gahr-20171231_cal.xml	Edgar Link	unprocessable
gahr-20171231_def.xml	Edgar Link	unprocessable
gahr-20171231_lab.xml	Edgar Link	unprocessable
gahr-20171231_pre.xml	Edgar Link	unprocessable
gahr4-10xk2017xq4.htm	Edgar Link	pending
gahr4orgchart020818003.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AHR
American Healthcare REIT, Inc. Stock $ahr

2016 Q4 Form 10-K Financial Statement

#000163297018000035 Filed on March 08, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AHR American Healthcare REIT, Inc. Stock $ahr

2016 Q4 Form 10-K Financial Statement

#000163297018000035 Filed on March 08, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AHR
American Healthcare REIT, Inc. Stock $ahr